BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16627419)

  • 1. Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation.
    Hemels ME; Wiesfeld AC; Inberg B; Van Dessel PF; Nieuwland W; Tan ES; Mulder H; Van Veldhuisen DJ; Van Gelder IC
    Europace; 2006 Feb; 8(2):107-12. PubMed ID: 16627419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study.
    Hemels ME; Ruiter JH; Molhoek GP; Veeger NJ; Wiesfeld AC; Ranchor AV; van Trigt M; Pilmeyer A; Van Gelder IC; ;
    Europace; 2008 Mar; 10(3):306-13. PubMed ID: 18245199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.
    Camm AJ; Sulke N; Edvardsson N; Ritter P; Albers BA; Ruiter JH; Lewalter T; Capucci PA; Hoffmann E;
    Europace; 2007 Dec; 9(12):1110-8. PubMed ID: 18042619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study.
    Lau CP; Tachapong N; Wang CC; Wang JF; Abe H; Kong CW; Liew R; Shin DG; Padeletti L; Kim YH; Omar R; Jirarojanakorn K; Kim YN; Chen MC; Sriratanasathavorn C; Munawar M; Kam R; Chen JY; Cho YK; Li YG; Wu SL; Bailleul C; Tse HF;
    Circulation; 2013 Aug; 128(7):687-93. PubMed ID: 23868858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
    de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP
    Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: a multicenter randomized study, the PAF-PACE study.
    Wiberg S; Lönnerholm S; Jensen SM; Blomström P; Ringqvist I; Blomström-Lundqvist C
    Pacing Clin Electrophysiol; 2003 Sep; 26(9):1841-8. PubMed ID: 12930498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation.
    Filipecki A; Saksena S; Lin WH
    Am J Cardiol; 2003 Nov; 92(9):1037-44. PubMed ID: 14583353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method of multisite atrial pacing, incorporating Bachmann's bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation.
    Lewicka-Nowak E; Kutarski A; Dabrowska-Kugacka A; Rucinski P; Zagozdzon P; Raczak G
    Europace; 2007 Sep; 9(9):805-11. PubMed ID: 17670780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention.
    Delfaut P; Saksena S; Prakash A; Krol RB
    J Am Coll Cardiol; 1998 Dec; 32(7):1900-8. PubMed ID: 9857870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Septal atrial pacing for the prevention of atrial fibrillation.
    Hakacova N; Velimirovic D; Margitfalvi P; Hatala R; Buckingham TA
    Europace; 2007 Dec; 9(12):1124-8. PubMed ID: 18024494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
    Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
    J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
    Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
    Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of concomitant drug therapy on the efficacy of atrial overdrive stimulation for prevention of atrial tachyarrhythmias.
    Konz KH; Danilovic D; Brachmann J; Attuel P; el Allaf D; John C; Malinowski K; Le Blanc U; Szendey I; Schibgilla V; Motzke T
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):272-7. PubMed ID: 12687827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of pacemaker therapy in the prevention of atrial fibrillation.
    Delfaut P; Prakash A; Giorgberidze I; Munsif AN; Mathew PP; Krol RB; Saksena S
    Semin Interv Cardiol; 1997 Dec; 2(4):219-25. PubMed ID: 9704356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy.
    Saksena S; Prakash A; Ziegler P; Hummel JD; Friedman P; Plumb VJ; Wyse DG; Johnson E; Fitts S; Mehra R;
    J Am Coll Cardiol; 2002 Sep; 40(6):1140-50; discussion 1151-2. PubMed ID: 12354441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.